<i id='30D7D4A89D'><strike id='30D7D4A89D'><tt id='30D7D4A89D'><pre id='30D7D4A89D'></pre></tt></strike></i> 
WASHINGTON — Former President Trump is back to campaigning for tying Medicare drug prices to lower prices abroad.
In Trump fashion, he claimed in a video announcement this month that he is the “only president in modern times” to take on the drug industry — and dinged President Biden directly.
advertisement
“Biden canceled my tough-on-pharma policies the moment he had a chance,” Trump said.
Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!
GET STARTED Log In
Hepatitis C has a cure — but many Americans still lack access to it 
AI models in health care face new federal disclosure requirements 
Drug repurposing or repositioning? The language matters 
New documents shed light on MD Anderson Cancer Institute feud 
Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections 
FDA needs staff influx to meet gene therapy needs, Marks says
Drug repurposing or repositioning? The language matters 
The Harvard botanist who searched for psychedelics in the Amazon 
DIEP, the 'gold standard' of breast reconstruction, is under threat 
The woman behind the Dana Farber 
Moonlake's readout produced a cash windfall. Risks remain 
Chemotherapy shortages won’t get better under Biden’s latest plan
Drug repurposing or repositioning? The language matters 
A solution to the after 
Heart attack and stroke risk calculators need revising 
